scholarly journals First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer

Cancer ◽  
2007 ◽  
Vol 110 (4) ◽  
pp. 752-758 ◽  
Author(s):  
Maria Giulia Zampino ◽  
Elena Magni ◽  
Cristian Massacesi ◽  
Alberto Zaniboni ◽  
Angelo Martignetti ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Growth Factor Receptor ◽  
Line Treatment ◽  
First Line ◽  
Epidermal Growth ◽  
Orally Active ◽  
First Line Treatment ◽  
Receptor Inhibitor

scholarly journals Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer

Cancer ◽  
2011 ◽  
Vol 118 (6) ◽  
pp. 1523-1532 ◽  
Author(s):  
Fotios Loupakis ◽  
Chiara Cremolini ◽  
Lisa Salvatore ◽  
Marta Schirripa ◽  
Sara Lonardi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Monoclonal Antibodies ◽  
Growth Factor ◽  
Growth Factor Receptor ◽  
Clinical Impact ◽  
Line Treatment ◽  
First Line ◽  
Epidermal Growth ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document